Upgrade of right ventricular pacing to cardiac resynchronization therapy in heart failure: a randomized trial.
Merkely B, Hatala R, Wranicz JK, Duray G, Földesi C, Som Z, Németh M, Goscinska-Bis K, Gellér L, Zima E, Osztheimer I, Molnár L, Karády J, Hindricks G, Goldenberg I, Klein H, Szigeti M, Solomon SD, Kutyifa V, Kovács A, Kosztin A.
Eur Heart J. 2023 Oct 21;44(40):4259-4269. doi: 10.1093/eurheartj/ehad591.
Long-Term Outcomes of Resynchronization-Defibrillation for Heart Failure.
Sapp JL, Sivakumaran S, Redpath CJ, Khan H, Parkash R, Exner DV, Healey JS, Thibault B, Sterns LD, Lam NHN, Manlucu J, Mokhtar A, Sumner G, McKinlay S, Kimber S, Mondesert B, Talajic M, Rouleau J, McCarron CE, Wells G, Tang ASL; RAFT Long-Term Study Team.
N Engl J Med. 2024 Jan 18;390(3):212-220. doi: 10.1056/NEJMoa2304542.
Cardiac resynchronization therapy with or without defibrillator in patients with heart failure.
Schrage B, Lund LH, Melin M, Benson L, Uijl A, Dahlström U, Braunschweig F, Linde C, Savarese G.
Europace. 2022 Jan 4;24(1):48-57. doi: 10.1093/europace/euab233.
Cardiac Resynchronization Therapy With or Without Defibrillation: A Long-Standing Debate.
Golzio PG, Bocchino PP, Bissolino A, Angelini F, Gravinese C, Frea S.
Cardiol Rev. 2022 Sep-Oct 01;30(5):221-233. doi: 10.1097/CRD.0000000000000388. Epub 2021 Mar 19.
Survival of patients undergoing cardiac resynchronization therapy with or without defibrillator: the RESET-CRT project.
Hadwiger M, Dagres N, Haug J, Wolf M, Marschall U, Tijssen J, Katalinic A, Frielitz FS, Hindricks G.
Eur Heart J. 2022 Jul 14;43(27):2591-2599. doi: 10.1093/eurheartj/ehac053.
Association of body mass index with cardiac resynchronization therapy intention and left ventricular lead implantation failure: insights from the NCDR implantable cardioverter-defibrillator registry.
Nishimura M, Marcus GM, Varosy PD, Bao H, Wang Y, Curtis JP, Hsu JC.
J Interv Card Electrophysiol. 2020 Mar;57(2):279-288. doi: 10.1007/s10840-019-00550-x. Epub 2019 Apr 19.
Follow-up and characteristics of recipients of cardiac resynchronization therapy with and without a defibrillator.
Grymuza M, Katarzyńska-Szymańska A, Chmielewska-Michalak L, Waśniewski M, Ochotny R, Lesiak M, Mitkowski P.
Kardiol Pol. 2022;80(7-8):806-812. doi: 10.33963/KP.a2022.0125. Epub 2022 May 12.
Cardiac Resynchronization Therapy and Risk of Recurrent Hospitalizations in Patients Without Left Bundle Branch Block: The Long-Term Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy.
Vidula H, Lee E, McNitt S, Polonsky B, Aktas M, Rosero S, Younis A, Solomon SD, Zareba W, Kutyifa V, Goldenberg I.
Circ Heart Fail. 2020 Jul;13(7):e006925. doi: 10.1161/CIRCHEARTFAILURE.120.006925. Epub 2020 Jul 1.
Mortality and cardiac resynchronization therapy with or without defibrillation in primary prevention.
Gras M, Bisson A, Bodin A, Herbert J, Babuty D, Pierre B, Clementy N, Fauchier L.
Europace. 2020 Aug 1;22(8):1224-1233. doi: 10.1093/europace/euaa096.
Use of Cardiac Resynchronization Therapy Defibrillator in US Hospitals.
Sandhu A, Bao H, Minges KE, Varosy PD, Borne RT, Zipse MM, Marzec L, Peterson P, Masoudi F, Bradley SM.
JAMA Cardiol. 2019 Aug 1;4(8):804-809. doi: 10.1001/jamacardio.2019.1755.
